• 13F History

Inspire Investing, LLC

13F Filings History

Latest 13F report
Q4 2024 - Jan 17, 2025
Value $
$894M
Signature - Title
Robert Netzly - President & CEO
Location
Meridian, ID
Summary
This page shows a list of all the recent 13F filings made by Inspire Investing, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Inspire Investing, LLC reported 824 stock holdings with total value $894M as of Q4 2024. Top holdings included USFR, ISRG, CAT, WWJD, and ANET.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 824 $894M +$99.3M -$155M -$55.7M USFR, ISRG, CAT, WWJD, ANET 13F-HR 1/17/2025, 04:13 PM
Q3 2024 827 $977M +$211M -$150M +$60.2M SMCI, IBD, CAT, USFR, ISRG 13F-HR 10/10/2024, 03:44 PM
Q2 2024 802 $868M +$93.1M -$171M -$78M IBD, USFR, CAT, ISRG, WWJD 13F-HR 8/12/2024, 05:01 PM
Q1 2024 787 $975M +$176M -$173M +$2.28M CAT, USFR, ISRG, IBD, PGR 13F-HR 5/7/2024, 04:51 PM
Q4 2023 785 $909M +$128M -$87.6M +$40.4M IBD, USFR, CAT, NOW, WWJD 13F-HR 2/12/2024, 02:43 PM
Q3 2023 791 $783M +$148M -$93.1M +$54.9M IBD, USFR, CAT, NOW, PLD 13F-HR 10/26/2023, 11:59 AM
Q2 2023 788 $827M +$130M -$92M +$38.5M IBD, USFR, ISRG, PLD, NOW 13F-HR 7/31/2023, 10:23 AM
Q1 2023 781 $785M +$116M -$75.4M +$40.4M USFR, IBD, PLD, ADI, NOW 13F-HR 4/24/2023, 10:24 AM
Q4 2022 743 $777M +$82.9M -$21.6M +$61.3M TFLO, USFR, IBD, WWJD, BLES 13F-HR 1/26/2023, 01:28 PM
Q3 2022 754 $708M +$138M -$94.2M +$43.4M USFR, TFLO, IBD, UUP, WWJD 13F-HR 11/7/2022, 04:01 PM
Q2 2022 762 $754M +$171M -$47.4M +$123M USFR, IBD, UUP, WWJD, BLES 13F-HR 8/10/2022, 12:37 PM
Q1 2022 788 $864M +$155M -$57M +$97.7M VGSH, IBD, PHYS, BLES, WWJD 13F-HR 4/21/2022, 10:10 AM
Q4 2021 785 $861M +$119M -$43.8M +$75.1M IBD, VGLT, ISRG, NOW, PLD Restatement 2/14/2022, 09:02 AM
Q3 2021 794 $791M +$422M -$359M +$63.5M IBD, VGLT, ISRG, NOW, BLES 13F-HR 11/9/2021, 02:02 PM
Q2 2021 593 $760M +$113M -$48.6M +$64.7M NVDA, IBD, BLES, VGLT, ISMD 13F-HR 8/10/2021, 04:58 PM
Q1 2021 597 $652M +$237M -$75.9M +$161M NVDA, IBD, VGIT, BLES, ISMD 13F-HR 4/30/2021, 12:07 PM
Q4 2020 622 $452M +$140M -$42.1M +$97.9M IBD, BLES, NVDA, ISMD, WWJD 13F-HR 2/12/2021, 01:47 PM
Q3 2020 432 $363M +$119M -$17.7M +$102M VGIT, IBD, BLES, NVDA, WWJD 13F-HR 11/16/2020, 03:27 PM
Q2 2020 485 $290M +$60.3M -$25.1M +$35.2M IBD, BLES, WWJD, ISMD, BIBL 13F-HR 8/12/2020, 03:46 PM
Q1 2020 735 $250M +$76.5M -$34.9M +$41.5M IBD, BLES, WWJD, ISMD, BIBL 13F-HR 5/8/2020, 04:44 PM
Q4 2019 351 $279M +$20.3M -$14.5M +$5.83M IBD, BLES, ISMD, BIBL, WWJD 13F-HR 1/24/2020, 11:28 AM
Q3 2019 375 $262M +$38.7M -$3.4M +$35.3M IBD, BLES, ISMD, BIBL, UNP 13F-HR 11/13/2019, 01:18 PM
Q2 2019 328 $238M +$30M -$8.87M +$21.1M IBD, BLES, ISMD, BIBL, UNP 13F-HR 7/16/2019, 01:32 PM
Q1 2019 297 $215M +$56M -$4.65M +$51.3M IBD, BLES, ISMD, BIBL, ABBV 13F-HR 5/16/2019, 07:42 AM
Q4 2018 242 $149M +$14M -$1.03M +$13M BLES, IBD, ISMD, BIBL, ABBV Restatement 2/21/2019, 05:01 PM
Q3 2018 237 $162M +$20.8M -$1.75M +$19M BLES, IBD, ISMD, BIBL, NVDA Restatement 2/21/2019, 04:59 PM
Q2 2018 220 $141M +$42.1M -$489K +$41.6M BLES, IBD, ISMD, BIBL, ABBV Restatement 2/21/2019, 04:59 PM
Q1 2018 199 $98.2M +$17.4M -$40.2K +$17.3M BLES, IBD, ISMD, BIBL, ITW Restatement 2/21/2019, 08:04 PM
Q4 2017 869 $117M BLES, IBD, ISMD, BIBL, JNPR Restatement 2/21/2019, 04:49 PM